Evaluation of the individual 50% inhibitory area under the concentration curve of 5-fluorouracil based on the collagen gel droplet embedded culture drug sensitivity test in colorectal cancer

Molecular Medicine Reports

Volumn 2, Issue 3, 2009, Pages 405-409

  Ochiai, Takumi ^a   Nishimura, Kazuhiko ^a   Watanabe, Tomoo ^a   Kitajima, Masayuki ^a   Tsuji, Masataka ^a   Nakatani, Akinori ^a   Nakayama, Noboru ^a   Marusasa, Takashi ^a   Mashiko, Satomi ^a   Nagaoka, Isao ^b   Futagawa, Shunji ^a  

^a Tokyo Metropolitan Health and Medical Treatment Corporation   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 fluorouracil; Area under the concentration curve; Collagen gel droplet embedded drug sensitivity test; Colorectal cancer; Individual AUC IR50

Indexed keywords

FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PATIENT; CANCER SURVIVAL; CHEMOSENSITIVITY; COLLAGEN GEL DROPLET EMBEDDED CULTURE DRUG SENSITIVITY TEST; COLORECTAL CANCER; COLORECTAL SURGERY; CONCENTRATION RESPONSE; DISEASE FREE SURVIVAL; DRUG DISTRIBUTION; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 69249138313     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000113     Document Type: Article

References (25)

1. Ochiai T, Nishimura K, Noguchi H, Kitajima M, Tsuruoka Y and Takahashi Y: Evaluation of 5-fluorouracil applicability by multi-point collagen gel droplet embedded drug sensitivity test. Oncol Rep 14: 201-205, 2005.
2. Ochiai T, Nishimura K, Noguchi H, et al: Evaluation of 5-fluorouracil applicability by the collagen gel droplet embedded drug sensitivity test with area under the curve analysis. Anticancer Drugs 18: 17-21, 2007. (Pubitemid 44949791)
3. Kobayashi H, Higashiyama M, Minamigawa K, et al: Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Jpn J Cancer Res 92: 203-210, 2001. (Pubitemid 32241776)
4. Hermans J, Bonenkamp JJ, Boon MC, et al: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11: 1441-1447, 1993. (Pubitemid 23228247)
5. Earle CC and Maroun JA : Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35: 1059-1064, 1999.
6. Mari E, Floriani I, Tinazzi A, et al: Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11: 837-843, 2000.
7. Janunger KG, Hafstrom L, Nygren P, Glimelius B; SBU-group, Swedish Council of Technology Assessment in Health Care: A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40: 309-326, 2001.
8. Panzini I, Gianni L, Fattori PP, et al: Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 88: 21-27, 2002. (Pubitemid 34269794)
9. Kitajima M, Takita N, Hata M, et al: The relationship between 5-fluorouracil sensitivity and single nucleotide polymorphisms of the orotate phosphoribosyl transferase gene in colorectal cancer. Oncol Rep 15: 161-165, 2006.
10. Iwahashi M, Nakamori M, Nakamura M, et al: Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer. Anticancer Res 25: 3453-3459, 2005. (Pubitemid 41105224)
11. Cree IA, Kurbacher CM, Untch M, et al: Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity. Anticancer Drugs 7: 630-635, 1996. (Pubitemid 26348840)
12. Kurbacher CM, Bruckner HW, Cree IA, et al: Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer; laboratory study and clinical pilot trial. Clin Cancer Res 3: 1527-1533, 1997.
13. Andreotti PE, Cree IA, Kurbacher CM, et al: Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res 55: 5276-5282, 1995.
14. Staib P, Staltmeier E, Ncurohr K, Cornely O, Reiser M and Schinkothe T: Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci. Br J Haematol 128: 783-791, 2005. (Pubitemid 40444870)
15. Takamura Y, Kobayashi H, Taguchi T, Motomura K, Inaji H and Noguchi S: Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers. Int J Cancer 98: 450-455, 2002. (Pubitemid 34188690)
16. Fujii R, Seshimo A and Kameoka S: Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma. Int J Clin Oncol 8: 72-78, 2003. (Pubitemid 36548474)
17. Mori S, Kunieda K, Sugiyama Y and Saji S: Prediction of 5-fluorouracil and cisplatin synergism for advanced gastrointestinal cancers using a collagen gel droplet embedded culture. Surg Today 33: 577-583, 2003. (Pubitemid 36936547)
18. Yabushita H, Ohnishi M, Komiyama M, et al: Usefulness of collagen gel droplet embedded culture drug sensitivity testing in ovarian cancer. Oncol Rep 12: 307-311, 2004.
19. Inoue Y, Gika M, Abiko T, et al: Bcl-2 overexpression enhances in vitro sensitivity against docetaxel in non-small cell lung cancer. Oncol Rep 13: 259-264, 2005.
20. Kawaguchi M, Banno K, Susumu N, et al: Successful analysis of anticancer drug sensitivity by CD-DST using pleural fluid and ascites from patients with advanced ovarian cancer: case reports. Anticancer Res 25: 3547-3551, 2005. (Pubitemid 41105239)
21. Okumura K, Shiomi H, Mekata E, et al: Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Oncol Rep 15: 875-882, 2006.
22. Kawamura M, Gika M, Abiko T, et al: Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST). Cancer Chemother Pharmacol 59: 507-513, 2007.
23. Shimizu T, Murata S, Mekata E, et al: Clinical potential of an antitumor drug sensitivity test and diffusion-weighted MRI in a patient with a recurrent solid pseudopapillary tumor of the pancreas. J Gastroenterol 42: 918-922, 2007. (Pubitemid 350142773)
24. Okumura K, Mekata E, Shiomi H, et al: Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer. Cancer Chemother Pharmacol 61: 587-594, 2008.
25. Matsuo A, Watanabe A, Takahashi T, et al: A simple method for classification of cell death by use of thin layer collagen gel for the detection of apoptosis and/or necrosis after cancer chemotherapy. Jpn J Cancer Res 92: 813-819, 2001. (Pubitemid 32747229)